LIONEX research activities include the following:

Human and Bovine TUBERCULOSIS and other infectious diseases: Vaccine and diagnostic product development

CANCER, specially urinary bladder cancer: A therapeutic protein ready for Phase I trials

LATERAL FLOW TECHNOLOGY: Manufacture of a series of lateral flow tests, innovation in this technology

HIV VACCINE DEVELOPMENT: A candidate vaccine ready for Phase II trials in collaboration with KCL

LIONEX is actively participating and/or coordinating a number of research projects funded by the European Union, The WHO, FIND, German Federal Ministry for Research and Education (BMBF), German Federal Ministry of Commerce (BMWi).  Research fields include diagnostics, vaccine and drug development, bladder cancer biomarkers and bladder cancer therapeutics.